Holen Sie sich die Stockscreener-App
17.05
0.47%
-0.08
Vorhandelsmarkt:
17.43
0.38
+2.23%
Schlusskurs vom Vortag:
$17.13
Offen:
$17.07
24-Stunden-Volumen:
2.40M
Relative Volume:
0.73
Marktkapitalisierung:
$4.07B
Einnahmen:
$426.45M
Nettoeinkommen (Verlust:
$197.67M
KGV:
20.79
EPS:
0.82
Netto-Cashflow:
$110.10M
1W Leistung:
-5.17%
1M Leistung:
-3.89%
6M Leistung:
+3.52%
1J Leistung:
+24.00%
1-Tages-Spanne:
$16.77
$17.27
1-Wochen-Bereich:
$16.50
$18.26
52-Wochen-Spanne:
$10.21
$25.67
Adma Biologics Inc Stock (ADMA) Company Profile
Firmenname
Adma Biologics Inc
Sektor
Branche
Telefon
(201) 478-5552
Adresse
C/O ADMA BIOLOGICS, INC., RAMSEY
Vergleichen Sie ADMA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
17.05 | 4.29B | 426.45M | 197.67M | 110.10M | 0.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-19 | Fortgesetzt | Raymond James | Strong Buy |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-11-11 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-06-04 | Eingeleitet | Jefferies | Buy |
| 2019-04-15 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-07 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-12-11 | Bestätigt | Maxim Group | Buy |
| 2017-11-14 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | Hochstufung | Maxim Group | Hold → Buy |
| 2016-08-01 | Herabstufung | Maxim Group | Buy → Hold |
| 2016-07-25 | Bestätigt | Maxim Group | Buy |
| 2015-05-13 | Bestätigt | Maxim Group | Buy |
| 2014-12-08 | Eingeleitet | Oppenheimer | Outperform |
| 2014-12-01 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Adma Biologics Inc Aktie (ADMA) Neueste Nachrichten
ADMA Biologics Inc. Stock Analysis and ForecastConsistent triple-digit returns - jammulinksnews.com
What analysts say about ADMA Biologics Inc. stockOutstanding risk-reward balance - jammulinksnews.com
What drives ADMA Biologics Inc. stock priceExplosive capital appreciation - jammulinksnews.com
Is ADMA Biologics Inc. a good long term investmentOutstanding stock performance - jammulinksnews.com
Adma Biologics (ADMA) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
We Think ADMA Biologics (NASDAQ:ADMA) Can Manage Its Debt With Ease - 富途牛牛
Institutional investors in ADMA Biologics, Inc. (NASDAQ:ADMA) lost 9.6% last week but have reaped the benefits of longer-term growth - simplywall.st
Where are the Opportunities in (ADMA) - news.stocktradersdaily.com
ADMA Biologics Plunges 4.89% Amid Insider Selling Concerns - AInvest
ADMA Biologics Shares Plunge 5.84% Amid Insider Trading Concerns - AInvest
How ADMA Biologics Inc. stock performs during market volatility3x Return Stock Radar - beatles.ru
ADMA Biologics' Insider Transactions: A Strategic Exit or a Vote of Confidence? - AInvest
Adma Biologics (ADMA) Declines More Than Market: Some Information for Investors - Yahoo Finance
ADMA Biologics, Inc. Rings the Nasdaq Stock Market Opening Bell - Nasdaq
ADMA Biologics, Inc. Rings the Opening Bell - Nasdaq
Adma Biologics (ADMA) Outperforms Broader Market: What You Need to Know - Yahoo Finance
(ADMA) Proactive Strategies - news.stocktradersdaily.com
Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy? - Yahoo Finance
(ADMA) Investment Analysis - news.stocktradersdaily.com
Adma Biologics (ADMA) Stock Drops Despite Market Gains: Important Facts to Note - MSN
Implied Volatility Surging for ADMA Biologics Stock Options - TradingView
Will Strong Asceniv Sales Drive ADMA Biologics Further? - Zacks Investment Research
ADMA vs Takeda: Which Plasma Therapy Stock Is the Better Buy Today? - Yahoo Finance
ADMA Biologics (ADMA) Drops 14.7% W/W as 3 Execs Unload Portfolios - Insider Monkey
Here's Why Adma Biologics (ADMA) Fell More Than Broader Market - Nasdaq
ADMA Biologics: A Rare Buying Opportunity Amid Insider Selling - AInvest
(ADMA) On The My Stocks Page - news.stocktradersdaily.com
ADMA Makes Notable Cross Below Critical Moving Average - Nasdaq
ADMA Looks to Expand Asceniv's Label: Will This Boost Sales? - sharewise
ADMA Biologics: Slowing Growth Warrants A Shift To Neutral (Rating Downgrade) - Seeking Alpha
ADMA Biologics Stock Soars Amid Biotech Growth Nasdaq Composite Gains - Kalkine Media
The 8.3% return this week takes ADMA Biologics' (NASDAQ:ADMA) shareholders three-year gains to 964% - simplywall.st
ADMA Biologics, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights – ADMA - ACCESS Newswire
Adma Biologics director sells $213,100 in stock - Investing.com Australia
Adma Biologics director sells $213,100 in stock By Investing.com - Investing.com South Africa
Finanzdaten der Adma Biologics Inc-Aktie (ADMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):